位置:首页 > 蛋白库 > RXFP1_HUMAN
RXFP1_HUMAN
ID   RXFP1_HUMAN             Reviewed;         757 AA.
AC   Q9HBX9; B4DHD1; B4DTV2; Q2M215; Q3KU24; Q3KU25; Q3KU26;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   03-AUG-2022, entry version 185.
DE   RecName: Full=Relaxin receptor 1;
DE   AltName: Full=Leucine-rich repeat-containing G-protein coupled receptor 7;
DE   AltName: Full=Relaxin family peptide receptor 1;
GN   Name=RXFP1; Synonyms=LGR7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND MUTAGENESIS OF ASP-637.
RX   PubMed=10935549; DOI=10.1210/mend.14.8.0510;
RA   Hsu S.Y., Kudo M., Chen T., Nakabayashi K., Bhalla A., van der Spek P.J.,
RA   van Duin M., Hsueh A.J.W.;
RT   "The three subfamilies of leucine-rich repeat-containing G protein-coupled
RT   receptors (LGR): identification of LGR6 and LGR7 and the signaling
RT   mechanism for LGR7.";
RL   Mol. Endocrinol. 14:1257-1271(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=16051677; DOI=10.1093/molehr/gah205;
RA   Muda M., He C., Martini P.G.V., Ferraro T., Layfield S., Taylor D.,
RA   Chevrier C., Schweickhardt R., Kelton C., Ryan P.L., Bathgate R.A.D.;
RT   "Splice variants of the relaxin and INSL3 receptors reveal unanticipated
RT   molecular complexity.";
RL   Mol. Hum. Reprod. 11:591-600(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 5).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=11517286; DOI=10.1093/molehr/7.9.799;
RA   Bartsch O., Bartlick B., Ivell R.;
RT   "Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and
RT   adenylyl cyclase activity.";
RL   Mol. Hum. Reprod. 7:799-809(2001).
RN   [8]
RP   INTERACTION WITH RLN3.
RX   PubMed=12506116; DOI=10.1074/jbc.m212457200;
RA   Sudo S., Kumagai J., Nishi S., Layfield S., Ferraro T., Bathgate R.A.D.,
RA   Hsueh A.J.W.;
RT   "H3 relaxin is a specific ligand for LGR7 and activates the receptor by
RT   interacting with both the ectodomain and the exoloop 2.";
RL   J. Biol. Chem. 278:7855-7862(2003).
RN   [9]
RP   GLYCOSYLATION AT ASN-36; ASN-127; ASN-264; ASN-272; ASN-325 AND ASN-368.
RX   PubMed=18533687; DOI=10.1021/bi800535b;
RA   Yan Y., Scott D.J., Wilkinson T.N., Ji J., Tregear G.W., Bathgate R.A.;
RT   "Identification of the N-linked glycosylation sites of the human relaxin
RT   receptor and effect of glycosylation on receptor function.";
RL   Biochemistry 47:6953-6968(2008).
RN   [10]
RP   INTERACTION WITH C1QTNF8.
RX   PubMed=24014093; DOI=10.1002/path.4257;
RA   Glogowska A., Kunanuvat U., Stetefeld J., Patel T.R., Thanasupawat T.,
RA   Krcek J., Weber E., Wong G.W., Del Bigio M.R., Hoang-Vu C.,
RA   Hombach-Klonisch S., Klonisch T.;
RT   "C1q-tumour necrosis factor-related protein 8 (CTRP8) is a novel
RT   interaction partner of relaxin receptor RXFP1 in human brain cancer
RT   cells.";
RL   J. Pathol. 231:466-479(2013).
RN   [11]
RP   STRUCTURE BY NMR OF 23-63 IN COMPLEX WITH CALCIUM IONS.
RX   PubMed=17148455; DOI=10.1074/jbc.m609526200;
RA   Hopkins E.J., Layfield S., Ferraro T., Bathgate R.A.D., Gooley P.R.;
RT   "The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein
RT   receptor class A module and identification of key residues in the N-
RT   terminal region of the module that mediate receptor activation.";
RL   J. Biol. Chem. 282:4172-4184(2007).
CC   -!- FUNCTION: Receptor for relaxins. The activity of this receptor is
CC       mediated by G proteins leading to stimulation of adenylate cyclase and
CC       an increase of cAMP. Binding of the ligand may also activate a tyrosine
CC       kinase pathway that inhibits the activity of a phosphodiesterase that
CC       degrades cAMP.
CC   -!- SUBUNIT: Interacts with C1QTNF8. {ECO:0000269|PubMed:24014093}.
CC   -!- INTERACTION:
CC       Q9HBX9; P24588: AKAP5; NbExp=2; IntAct=EBI-8088969, EBI-703640;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16051677};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:16051677}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q9HBX9-1; Sequence=Displayed;
CC       Name=2; Synonyms=LGR7.10;
CC         IsoId=Q9HBX9-2; Sequence=VSP_001984;
CC       Name=3; Synonyms=LGR7.1;
CC         IsoId=Q9HBX9-3; Sequence=VSP_029877, VSP_029878;
CC       Name=4; Synonyms=LGR7.2;
CC         IsoId=Q9HBX9-4; Sequence=VSP_029879;
CC       Name=5;
CC         IsoId=Q9HBX9-5; Sequence=VSP_054375, VSP_054376;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, kidney, testis, placenta,
CC       uterus, ovary, adrenal, prostate, skin and heart. Not detected in
CC       spleen. {ECO:0000269|PubMed:16051677}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF190500; AAG17167.1; -; mRNA.
DR   EMBL; AY899848; AAX85196.1; -; mRNA.
DR   EMBL; AY899849; AAX85197.1; -; mRNA.
DR   EMBL; AY899850; AAX85198.1; -; mRNA.
DR   EMBL; AK295040; BAG58092.1; -; mRNA.
DR   EMBL; AK300379; BAG62114.1; -; mRNA.
DR   EMBL; AC019341; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107219; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC121161; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125489; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471056; EAX04856.1; -; Genomic_DNA.
DR   EMBL; BC112142; AAI12143.1; -; mRNA.
DR   EMBL; BC113617; AAI13618.1; -; mRNA.
DR   CCDS; CCDS43276.1; -. [Q9HBX9-1]
DR   CCDS; CCDS58929.1; -. [Q9HBX9-4]
DR   CCDS; CCDS58930.1; -. [Q9HBX9-2]
DR   RefSeq; NP_001240657.1; NM_001253728.1. [Q9HBX9-2]
DR   RefSeq; NP_001240658.1; NM_001253729.1. [Q9HBX9-4]
DR   RefSeq; NP_067647.2; NM_021634.3. [Q9HBX9-1]
DR   PDB; 2JM4; NMR; -; A=23-63.
DR   PDB; 2M7P; NMR; -; A=28-39.
DR   PDBsum; 2JM4; -.
DR   PDBsum; 2M7P; -.
DR   AlphaFoldDB; Q9HBX9; -.
DR   SASBDB; Q9HBX9; -.
DR   SMR; Q9HBX9; -.
DR   BioGRID; 121891; 86.
DR   IntAct; Q9HBX9; 5.
DR   MINT; Q9HBX9; -.
DR   STRING; 9606.ENSP00000405841; -.
DR   BindingDB; Q9HBX9; -.
DR   ChEMBL; CHEMBL1293316; -.
DR   GuidetoPHARMACOLOGY; 351; -.
DR   TCDB; 9.A.14.1.19; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; Q9HBX9; 6 sites.
DR   iPTMnet; Q9HBX9; -.
DR   PhosphoSitePlus; Q9HBX9; -.
DR   BioMuta; RXFP1; -.
DR   DMDM; 166209887; -.
DR   MassIVE; Q9HBX9; -.
DR   MaxQB; Q9HBX9; -.
DR   PaxDb; Q9HBX9; -.
DR   PeptideAtlas; Q9HBX9; -.
DR   PRIDE; Q9HBX9; -.
DR   ProteomicsDB; 4211; -.
DR   ProteomicsDB; 81607; -. [Q9HBX9-1]
DR   ProteomicsDB; 81608; -. [Q9HBX9-2]
DR   ABCD; Q9HBX9; 9 sequenced antibodies.
DR   Antibodypedia; 7543; 327 antibodies from 33 providers.
DR   DNASU; 59350; -.
DR   Ensembl; ENST00000307765.10; ENSP00000303248.5; ENSG00000171509.16. [Q9HBX9-1]
DR   Ensembl; ENST00000343542.9; ENSP00000345889.5; ENSG00000171509.16. [Q9HBX9-4]
DR   Ensembl; ENST00000470033.2; ENSP00000420712.1; ENSG00000171509.16. [Q9HBX9-2]
DR   Ensembl; ENST00000471616.5; ENSP00000434475.1; ENSG00000171509.16. [Q9HBX9-3]
DR   GeneID; 59350; -.
DR   KEGG; hsa:59350; -.
DR   MANE-Select; ENST00000307765.10; ENSP00000303248.5; NM_021634.4; NP_067647.2.
DR   UCSC; uc003ipz.4; human. [Q9HBX9-1]
DR   CTD; 59350; -.
DR   DisGeNET; 59350; -.
DR   GeneCards; RXFP1; -.
DR   HGNC; HGNC:19718; RXFP1.
DR   HPA; ENSG00000171509; Tissue enhanced (adrenal gland, brain, endometrium).
DR   MIM; 606654; gene.
DR   neXtProt; NX_Q9HBX9; -.
DR   OpenTargets; ENSG00000171509; -.
DR   PharmGKB; PA134868312; -.
DR   VEuPathDB; HostDB:ENSG00000171509; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG2087; Eukaryota.
DR   GeneTree; ENSGT00940000158241; -.
DR   HOGENOM; CLU_1431019_0_0_1; -.
DR   InParanoid; Q9HBX9; -.
DR   PhylomeDB; Q9HBX9; -.
DR   TreeFam; TF326185; -.
DR   PathwayCommons; Q9HBX9; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-444821; Relaxin receptors.
DR   Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production.
DR   SignaLink; Q9HBX9; -.
DR   SIGNOR; Q9HBX9; -.
DR   BioGRID-ORCS; 59350; 9 hits in 1060 CRISPR screens.
DR   ChiTaRS; RXFP1; human.
DR   EvolutionaryTrace; Q9HBX9; -.
DR   GeneWiki; Relaxin/insulin-like_family_peptide_receptor_1; -.
DR   GenomeRNAi; 59350; -.
DR   Pharos; Q9HBX9; Tchem.
DR   PRO; PR:Q9HBX9; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9HBX9; protein.
DR   Bgee; ENSG00000171509; Expressed in decidua and 106 other tissues.
DR   ExpressionAtlas; Q9HBX9; baseline and differential.
DR   Genevisible; Q9HBX9; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:MGI.
DR   GO; GO:0042562; F:hormone binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0060427; P:lung connective tissue development; IEA:Ensembl.
DR   GO; GO:0036446; P:myofibroblast differentiation; IEA:Ensembl.
DR   GO; GO:0060658; P:nipple morphogenesis; IEA:Ensembl.
DR   GO; GO:0007567; P:parturition; IEA:Ensembl.
DR   CDD; cd00112; LDLa; 1.
DR   Gene3D; 3.80.10.10; -; 2.
DR   Gene3D; 4.10.400.10; -; 1.
DR   IDEAL; IID00681; -.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR036055; LDL_receptor-like_sf.
DR   InterPro; IPR023415; LDLR_class-A_CS.
DR   InterPro; IPR002172; LDrepeatLR_classA_rpt.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008112; Relaxin_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF00057; Ldl_recept_a; 1.
DR   Pfam; PF13855; LRR_8; 2.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01739; RELAXINR.
DR   SMART; SM00192; LDLa; 1.
DR   SMART; SM00369; LRR_TYP; 9.
DR   SUPFAM; SSF57424; SSF57424; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
DR   PROSITE; PS01209; LDLRA_1; 1.
DR   PROSITE; PS50068; LDLRA_2; 1.
DR   PROSITE; PS51450; LRR; 10.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Leucine-rich repeat; Membrane;
KW   Metal-binding; Receptor; Reference proteome; Repeat; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..757
FT                   /note="Relaxin receptor 1"
FT                   /id="PRO_0000069700"
FT   TOPO_DOM        1..409
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        410..430
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        431..443
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        444..464
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        465..486
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        487..507
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        508..527
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        528..548
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        549..577
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        578..598
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        599..629
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        630..650
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        651
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        652..672
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        673..757
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          26..63
FT                   /note="LDL-receptor class A"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00124"
FT   DOMAIN          91..127
FT                   /note="LRRNT"
FT   REPEAT          151..172
FT                   /note="LRR 1"
FT   REPEAT          175..196
FT                   /note="LRR 2"
FT   REPEAT          199..220
FT                   /note="LRR 3"
FT   REPEAT          223..244
FT                   /note="LRR 4"
FT   REPEAT          248..269
FT                   /note="LRR 5"
FT   REPEAT          272..293
FT                   /note="LRR 6"
FT   REPEAT          296..317
FT                   /note="LRR 7"
FT   REPEAT          320..341
FT                   /note="LRR 8"
FT   REPEAT          344..365
FT                   /note="LRR 9"
FT   BINDING         45
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         48
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         50
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         52
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         58
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   BINDING         59
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   CARBOHYD        127
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   CARBOHYD        264
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   CARBOHYD        325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   CARBOHYD        368
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18533687"
FT   DISULFID        27..40
FT   DISULFID        34..53
FT   DISULFID        47..62
FT   DISULFID        485..563
FT   VAR_SEQ         1..81
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054375"
FT   VAR_SEQ         63..96
FT                   /note="GDNNGWSLQFDKYFASYYKMTSQYPFEAETPECL -> V (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:10935549,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:16051677"
FT                   /id="VSP_001984"
FT   VAR_SEQ         180..189
FT                   /note="YLSHNRITFL -> SRAVKDGSEK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16051677"
FT                   /id="VSP_029877"
FT   VAR_SEQ         190..757
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16051677"
FT                   /id="VSP_029878"
FT   VAR_SEQ         252..275
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054376"
FT   VAR_SEQ         300..348
FT                   /note="LDLGSNKIENLPPLIFKDLKELSQLNLSYNPIQKIQANQFDYLVKLKSL ->
FT                   F (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16051677"
FT                   /id="VSP_029879"
FT   MUTAGEN         637
FT                   /note="D->Y: Leads to constitutive increase of basal cAMP."
FT                   /evidence="ECO:0000269|PubMed:10935549"
FT   CONFLICT        70
FT                   /note="L -> M (in Ref. 1; AAG17167)"
FT                   /evidence="ECO:0000305"
FT   STRAND          31..33
FT                   /evidence="ECO:0007829|PDB:2JM4"
FT   STRAND          35..38
FT                   /evidence="ECO:0007829|PDB:2JM4"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:2JM4"
FT   HELIX           43..45
FT                   /evidence="ECO:0007829|PDB:2JM4"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:2JM4"
SQ   SEQUENCE   757 AA;  86975 MW;  B32DD71B1A5D5864 CRC64;
     MTSGSVFFYI LIFGKYFSHG GGQDVKCSLG YFPCGNITKC LPQLLHCNGV DDCGNQADED
     NCGDNNGWSL QFDKYFASYY KMTSQYPFEA ETPECLVGSV PVQCLCQGLE LDCDETNLRA
     VPSVSSNVTA MSLQWNLIRK LPPDCFKNYH DLQKLYLQNN KITSISIYAF RGLNSLTKLY
     LSHNRITFLK PGVFEDLHRL EWLIIEDNHL SRISPPTFYG LNSLILLVLM NNVLTRLPDK
     PLCQHMPRLH WLDLEGNHIH NLRNLTFISC SNLTVLVMRK NKINHLNENT FAPLQKLDEL
     DLGSNKIENL PPLIFKDLKE LSQLNLSYNP IQKIQANQFD YLVKLKSLSL EGIEISNIQQ
     RMFRPLMNLS HIYFKKFQYC GYAPHVRSCK PNTDGISSLE NLLASIIQRV FVWVVSAVTC
     FGNIFVICMR PYIRSENKLY AMSIISLCCA DCLMGIYLFV IGGFDLKFRG EYNKHAQLWM
     ESTHCQLVGS LAILSTEVSV LLLTFLTLEK YICIVYPFRC VRPGKCRTIT VLILIWITGF
     IVAFIPLSNK EFFKNYYGTN GVCFPLHSED TESIGAQIYS VAIFLGINLA AFIIIVFSYG
     SMFYSVHQSA ITATEIRNQV KKEMILAKRF FFIVFTDALC WIPIFVVKFL SLLQVEIPGT
     ITSWVVIFIL PINSALNPIL YTLTTRPFKE MIHRFWYNYR QRKSMDSKGQ KTYAPSFIWV
     EMWPLQEMPP ELMKPDLFTY PCEMSLISQS TRLNSYS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024